Ownership signal 1 fact
Subject security 2 facts
Symbol
THRD
Shares outstanding
45,416,671 shares
SEC evidence 4 facts
Form type
SCHEDULE 13G
Accepted by SEC
14 Feb 2025, 11:03:06 UTC
Event date
11 Feb 2025
SEC filing
View on sec.gov

Key filing fact

BML Investment Partners, L.P. disclosed 8.2% ownership in Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share (THRD) on 11 Feb 2025.

Key facts

  • BML Investment Partners, L.P. filed SCHEDULE 13G for Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share (THRD).
  • Disclosed ownership: 8.2%.
  • Date of event: 11 Feb 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 11:03.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (1)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BML Investment Partners, L.P. 8.2% 3,724,167 0 3,724,167 Braden M Leonard BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .